What is the share price of Torrent Pharmaceuticals Ltd (TORNTPHARM) today?
The share price of TORNTPHARM as on 16th July 2026 is ₹4987.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The past returns of Torrent Pharmaceuticals Ltd (TORNTPHARM) share are- Past 1 week: 2.41%
- Past 1 month: 10.13%
- Past 3 months: 20.01%
- Past 6 months: 24.13%
- Past 1 year: 44.17%
- Past 3 years: 156.41%
- Past 5 years: 233.53%
What are the peers or stocks similar to Torrent Pharmaceuticals Ltd (TORNTPHARM)?
The peers or stocks similar to Torrent Pharmaceuticals Ltd (TORNTPHARM) include:What is the dividend yield % of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The current dividend yield of Torrent Pharmaceuticals Ltd (TORNTPHARM) is 0.76.What is the market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹169825.15 Cr as of 16th July 2026.What is the 52 week high and low of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The 52-week high of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹5085.80 and the 52-week low is ₹3421.30.What is the PE and PB ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM) stock?
The P/E (price-to-earnings) ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM) is 78.50. The P/B (price-to-book) ratio is 9.66.Which sector does Torrent Pharmaceuticals Ltd (TORNTPHARM) belong to?
Torrent Pharmaceuticals Ltd (TORNTPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares?
You can directly buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Torrent Pharmaceuticals Ltd
TORNTPHARM Share Price
NSE₹4,987.600.60% (-30.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TORNTPHARM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is overpriced and in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TORNTPHARM Performance & Key Metrics
TORNTPHARM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 79.43 | 9.66 | 0.76% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.35 | 6.25 | 0.49% |
79%
Analysts have suggested that investors can buy this stock
from 28 analysts
Price Upside
Earnings Growth
Rev. Growth
TORNTPHARM Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
SUNPHARMA
PE Ratio
40.79
40.79
1Y Return
14.64%
14.64%
Buy Reco %
93.75
93.75
CIPLA
PE Ratio
29.95
29.95
1Y Return
3.14%
3.14%
Buy Reco %
65.71
65.71
ZYDUSLIFE
PE Ratio
22.90
22.90
1Y Return
19.09%
19.09%
Buy Reco %
55.17
55.17
LUPIN
PE Ratio
21.37
21.37
1Y Return
29.55%
29.55%
Buy Reco %
55.56
55.56
MANKIND
PE Ratio
54.90
54.90
1Y Return
3.03%
3.03%
Buy Reco %
87.50
87.50
TORNTPHARM Sentiment Analysis
TORNTPHARM Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TORNTPHARM Stock Summary · May 2026
Strong quarter driven by robust India growth and new product launches, though near‑term margin pressure from new product economics and acquisition accounting was flagged. Consolidated Q4 revenue rose 42% year‑on‑year to INR 4,197 crore and operating EBITDA expanded with a 32.3% operating margin. Management emphasized execution: the India base business outpaced the market and field‑force expansion and OTC advertising supported key franchises, while two semaglutide brands led generic launches but will start with lower gross margins and elevated launch spend that depress initial injectable EBITDA; oral margins are also below injectable but expected to improve as API costs fall and volumes scale, with possible temporary low‑dose supply constraints. The recent acquisition added one‑off integration charges and a substantial amortization charge, while synergies of up to INR 450 crore are being pursued on a 20‑60‑20 phasing and are tracking ahead in parts. International growth was driven by new introductions in Brazil and steady US/Europe activity, R&D is being reallocated toward India and the US, and management expects organic India growth in FY27 to be mid‑teens, conditional on no external demand shocks.
TORNTPHARM Stock Growth Drivers
TORNTPHARM Stock Growth Drivers
6Robust financial performance and margin resilience
The company delivered materially stronger financial results with consolidated Q4 revenue up 42% YoY to
Strong India franchise with scalable commercial footprint
The India business outperformed peers and the market, reporting quarterly India revenue of INR 2,215
TORNTPHARM Stock Challenges
TORNTPHARM Stock Challenges
5Acquisition and integration-related financial and operational headwinds
The recent acquisition and integration are producing multiple realized and ongoing negative impacts: JB Pharma's
Semaglutide regulatory, market-share shift and margin pressure
The semaglutide opportunity faces immediate commercial and regulatory headwinds that shrink near‑term profitability: in Brazil,
TORNTPHARM Forecast
TORNTPHARM Forecasts
Price
Revenue
Earnings
TORNTPHARM Share Price Forecast
TORNTPHARM Share Price Forecast
2026
Current
₹4,987.60
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹4,987.60
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TORNTPHARM Company Revenue Forecast
TORNTPHARM Company Revenue Forecast
2026
Current
₹19.18
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹19.18
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
TORNTPHARM Stock EPS (Earnings Per Share) Forecast
TORNTPHARM Stock EPS (Earnings Per Share) Forecast
2026
Current
₹63.92
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹63.92
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TORNTPHARM
TORNTPHARM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TORNTPHARM Income Statement
TORNTPHARM Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,787.00 | 2,776.00 | 2,883.00 | 2,873.00 | 2,842.00 | 2,941.00 | 3,141.00 | 3,275.00 | 3,290.00 | 4,180.00 | ||||||||||
Operating & Other expenses | 1,863.00 | 1,862.00 | 1,955.00 | 1,950.00 | 1,895.00 | 2,019.00 | 2,146.00 | 2,232.00 | 2,225.00 | 2,907.00 | ||||||||||
EBITDA | 924.00 | 914.00 | 928.00 | 923.00 | 947.00 | 922.00 | 995.00 | 1,043.00 | 1,065.00 | 1,273.00 | ||||||||||
| Depreciation/Amortization | 213.00 | 203.00 | 197.00 | 198.00 | 199.00 | 201.00 | 201.00 | 204.00 | 206.00 | 508.00 | ||||||||||
| PBIT | 711.00 | 711.00 | 731.00 | 725.00 | 748.00 | 721.00 | 794.00 | 839.00 | 859.00 | 765.00 | ||||||||||
| Interest & Other Items | 80.00 | 80.00 | 75.00 | 64.00 | 57.00 | 56.00 | 56.00 | 48.00 | 45.00 | 236.00 | ||||||||||
| PBT | 631.00 | 631.00 | 656.00 | 661.00 | 691.00 | 665.00 | 738.00 | 791.00 | 814.00 | 529.00 | ||||||||||
| Taxes & Other Items | 188.00 | 182.00 | 199.00 | 208.00 | 188.00 | 167.00 | 190.00 | 200.00 | 179.00 | 165.00 | ||||||||||
| Net Income | 443.00 | 449.00 | 457.00 | 453.00 | 503.00 | 498.00 | 548.00 | 591.00 | 635.00 | 364.00 | ||||||||||
| EPS | 13.10 | 13.27 | 13.51 | 13.37 | 14.88 | 14.71 | 16.19 | 17.54 | 18.77 | 11.51 |
TORNTPHARM Company Updates
TORNTPHARM Stock Peers
TORNTPHARM Past Performance & Peer Comparison
TORNTPHARM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd | 78.50 | 9.66 | 0.76% |
| Sun Pharmaceutical Industries Ltd | 40.79 | 5.58 | 0.82% |
| Cipla Ltd | 29.95 | 3.37 | 0.90% |
| Zydus Lifesciences Ltd | 22.90 | 3.90 | 0.09% |
TORNTPHARM Stock Price Comparison
Compare TORNTPHARM with any stock or ETFCompare TORNTPHARM with any stock or ETF
TORNTPHARM
TORNTPHARM Holdings
TORNTPHARM Shareholdings
TORNTPHARM Promoter Holdings Trend
TORNTPHARM Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TORNTPHARM Institutional Holdings Trend
TORNTPHARM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TORNTPHARM Shareholding Pattern
TORNTPHARM Shareholding Pattern
TORNTPHARM Shareholding History
TORNTPHARM Shareholding History
Foreign Institutions
Mutual Funds Invested in TORNTPHARM
Mutual Funds Invested in TORNTPHARM
No mutual funds holding trends are available
Top 5 Mutual Funds holding Torrent Pharmaceuticals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1121% | Percentage of the fund’s portfolio invested in the stock 1.16% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 76/125 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1024% | Percentage of the fund’s portfolio invested in the stock 1.61% | Change in the portfolio weight of the stock over the last 3 months 0.79% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/69 (+43) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0817% | Percentage of the fund’s portfolio invested in the stock 1.98% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 23/51 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TORNTPHARM stock
smallcases containing TORNTPHARM stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Torrent Pharmaceuticals Ltd
TORNTPHARM Events
TORNTPHARM Events
TORNTPHARM Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.76%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.57 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TORNTPHARM Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.76%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.57 every year
TORNTPHARM Upcoming Dividends
TORNTPHARM Upcoming Dividends
No upcoming dividends are available
TORNTPHARM Past Dividends
TORNTPHARM Past Dividends
Cash Dividend
Ex DateEx DateMay 29, 2026
Final
Final | Div/Share: ₹9.00
Dividend/Share
₹9.00
Ex DateEx Date
May 29, 2026
Cash Dividend
Ex DateEx DateFeb 18, 2026
Interim
Interim | Div/Share: ₹29.00
Dividend/Share
₹29.00
Ex DateEx Date
Feb 18, 2026
Cash Dividend
Ex DateEx DateJun 20, 2025
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Jun 20, 2025
Cash Dividend
Ex DateEx DateJan 31, 2025
Interim
Interim | Div/Share: ₹26.00
Dividend/Share
₹26.00
Ex DateEx Date
Jan 31, 2025
Cash Dividend
Ex DateEx DateJun 21, 2024
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Jun 21, 2024
TORNTPHARM Stock News & Opinions
TORNTPHARM Stock News & Opinions
Articles & Videos
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd spurts 0.67%, up for five straight sessionsTorrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 4855.1, up 0.67% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.17% on the day, quoting at 24472.4. The Sensex is at 78420.16, up 0.17%. Torrent Pharmaceuticals Ltd has added around 10.08% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has added around 6.88% in last one month and is currently quoting at 25866.25, down 0.22% on the day. The volume in the stock stood at 3.51 lakh shares today, compared to the daily average of 4.85 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 4858, up 0.58% on the day. Torrent Pharmaceuticals Ltd is up 46.13% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% fall in the Nifty Pharma index.The PE of the stock is 73.79 based on TTM earnings ending March 26.Powered by Capital Market - Live
1 week agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd soars 2.35%Torrent Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 4770.9, up 2.35% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.74% on the day, quoting at 24354.25. The Sensex is at 78056.84, up 0.72%. Torrent Pharmaceuticals Ltd has risen around 9.93% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has risen around 6.77% in last one month and is currently quoting at 25308.9, up 2% on the day. The volume in the stock stood at 1.84 lakh shares today, compared to the daily average of 5.05 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 4787.5, up 2.07% on the day. Torrent Pharmaceuticals Ltd is up 41.65% in last one year as compared to a 4.35% drop in NIFTY and a 15.33% drop in the Nifty Pharma index.The PE of the stock is 71.33 based on TTM earnings ending March 26.Powered by Capital Market - Live
1 week agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd eases for fifth straight sessionTorrent Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 4426.6, down 0.36% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.13% on the day, quoting at 24116.9. The Sensex is at 77301.67, up 0.19%.Torrent Pharmaceuticals Ltd has eased around 0.75% in last one month.Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has eased around 2.88% in last one month and is currently quoting at 24146.55, up 0.01% on the day. The volume in the stock stood at 1.31 lakh shares today, compared to the daily average of 5.7 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 4443.7, down 0.39% on the day. Torrent Pharmaceuticals Ltd jumped 39.91% in last one year as compared to a 2.73% slide in NIFTY and a 12.63% spurt in the Nifty Pharma index.The PE of the stock is 68.05 based on TTM earnings ending March 26.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals schedules AGMTorrent Pharmaceuticals announced that the 53th Annual General Meeting(AGM) of the company will be held on 23 June 2026.
1 month agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd spurts 3.06%, rises for third straight sessionTorrent Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 4623.4, up 3.06% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.94% on the day, quoting at 23941.85. The Sensex is at 76196.93, up 1.04%. Torrent Pharmaceuticals Ltd has added around 9.56% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has added around 6.21% in last one month and is currently quoting at 24573.95, up 0.15% on the day. The volume in the stock stood at 6.75 lakh shares today, compared to the daily average of 2.81 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 4589, up 2.68% on the day. Torrent Pharmaceuticals Ltd is up 45.05% in last one year as compared to a 4.24% fall in NIFTY and a 14.46% fall in the Nifty Pharma index.The PE of the stock is 67.95 based on TTM earnings ending December 25.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Board of Torrent Pharmaceuticals recommends final dividendTorrent Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 9 per equity Share (i.e. 180%) , subject to the approval of the shareholders.
1 month agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals fixes record date for final dividendTorrent Pharmaceuticals has fixed 29 May 2026 as record date for purpose of payment of final dividend for FY 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Torrent Pharmaceuticals consolidated net profit declines 26.91% in the March 2026 quarterNet profit of Torrent Pharmaceuticals declined 26.91% to Rs 364.00 crore in the quarter ended March 2026 as against Rs 498.00 crore during the previous quarter ended March 2025. Sales rose 41.90% to Rs 4128.00 crore in the quarter ended March 2026 as against Rs 2909.00 crore during the previous quarter ended March 2025. For the full year,net profit rose 11.88% to Rs 2138.00 crore in the year ended March 2026 as against Rs 1911.00 crore during the previous year ended March 2025. Sales rose 21.53% to Rs 13753.00 crore in the year ended March 2026 as against Rs 11317.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales4128.002909.00 42 13753.0011317.00 22 OPM %32.8533.14 -33.1532.88 - PBDT1103.00890.00 24 4080.003492.00 17 PBT595.00689.00 -14 2961.002697.00 10 NP364.00498.00 -27 2138.001911.00 12 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals to convene board meetingTorrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 May 2026.
2 months agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd spurts 0.14%, up for five straight sessionsTorrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 4369, up 0.14% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. Torrent Pharmaceuticals Ltd has added around 6.7% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has added around 9.02% in last one month and is currently quoting at 24135.5, down 0.02% on the day. The volume in the stock stood at 67292 shares today, compared to the daily average of 3.37 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 4385.1, up 0.22% on the day. Torrent Pharmaceuticals Ltd is up 39.09% in last one year as compared to a 0.65% gain in NIFTY and a 14.52% gain in the Nifty Pharma index.The PE of the stock is 66.05 based on TTM earnings ending December 25.Powered by Capital Market - Live
2 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 18.93%, vs industry avg of 12.39%
Over the last 5 years, market share increased from 2.85% to 3.76%
Over the last 5 years, net income has grown at a yearly rate of 11.56%, vs industry avg of 10.55%